GlassScriptPhysician profile
Amy Gage Weber
NPI 1467726232
$2,109.69
in general payments reported to CMS, 2019-2025
36 companies · $47.03 in 2025
The $47.03 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,469 · 2022: $532 · 2023: $45.69 · 2024: $16.91 · 2025: $47.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319.41 | 2021-2023 | |
| Jazz Pharmaceuticals INC. | $180.91 | 2021-2022 | |
| Amgen INC. | $141.03 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $138.43 | 2021-2025 | |
| Genzyme Corporation | $126.54 | 2021-2022 | |
| Ucb, INC. | $112.90 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $85.31 | 2021-2022 | |
| Biogen, INC. | $85.06 | 2021-2022 | |
| Grifols USA, LLC | $83.48 | 2021-2022 | |
| Kyowa Kirin, INC. | $64.61 | 2021-2022 | |
| Sk Life Science, INC. | $61.03 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $55.10 | 2021 | |
| Alexion Pharmaceuticals, INC. | $52.56 | 2021 | |
| Pfizer INC. | $52.40 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $48.85 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $48.76 | 2022 | |
| Sunovion Pharmaceuticals INC. | $45.22 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $44.25 | 2021 | |
| Eisai INC. | $39.52 | 2022 | |
| Avanir Pharmaceuticals, INC. | $31.07 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $30.64 | 2021 | |
| Csl Behring | $29.28 | 2021 | |
| Alfasigma USA, INC. | $24.84 | 2021 | |
| Acadia Pharmaceuticals INC | $24.42 | 2021 | |
| Harmony Biosciences LLC | $24.04 | 2021 | |
| Lilly USA, LLC | $16.52 | 2021 | |
| Allergan, INC. | $16.38 | 2021 | |
| Supernus Pharmaceuticals, INC. | $15.50 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.45 | 2021 | |
| Currax Pharmaceuticals LLC | $15.10 | 2021 | |
| Celgene Corporation | $15.03 | 2023 | Zeposia |
| Sanofi-Aventis U.S. LLC | $14.83 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.61 | 2021 | |
| Mdd US Operations, LLC | $13.34 | 2022 | |
| Avion Pharmaceuticals | $12.03 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.